News Conference News TCT 2019 LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD L.A. McKeown September 28, 2019
News Conference News TCT 2019 ‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures L.A. McKeown September 28, 2019
News Conference News TCT 2019 TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More Shelley Wood September 19, 2019
News Conference News EuroPCR 2019 EFFPAC: Novel Paclitaxel DCB for PAD Demonstrates Efficacy With No Mortality Signal L.A. McKeown May 23, 2019
News Conference News EuroPCR 2019 BASKET-SMALL 2 Angiographic Substudy Supports Safety of DCBs in Small Coronary Vessels L.A. McKeown May 22, 2019
News Conference News EuroPCR 2019 Drug-Coated Balloons in STEMI ‘Safe and Feasible’ in Specific Circumstances: REVELATION L.A. McKeown May 22, 2019
News Conference News SCAI 2019 Paclitaxel DCBs and CHIP: SCAI Kicks Off With Two Hot-Potato Topics Yael L. Maxwell May 21, 2019
News Conference News EuroPCR 2019 Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements Shelley Wood May 16, 2019
News Conference News CRT 2019 SAFE-DCB Demonstrates Consistent Efficacy at 1 Year in Real-world Femoropopliteal Disease Patients Yael L. Maxwell March 14, 2019
News Conference News CRT 2019 Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy L.A. McKeown March 06, 2019
News Conference News ISET 2019 Eluvia Sustains Lead Over Zilver PTX in Patients With Diabetes: IMPERIAL Subanalysis Caitlin E. Cox January 30, 2019
News Conference News ISET 2019 Paclitaxel in PAD: What to Tell Patients While the Numbers Are Crunched Caitlin E. Cox January 28, 2019
News Conference News VIVA 2018 No Gender Difference in Patency Rates 1 Year After DCB for PAD: ILLUMENATE Substudy L.A. McKeown November 13, 2018
News Conference News VIVA 2018 LUTONIX BTK: Hope for Challenging Patients at High Risk for Amputation L.A. McKeown November 07, 2018
News Conference News VIVA 2018 IMPERIAL Substudy Provides Reassurance for Benefit of Eluvia in Long Lesions L.A. McKeown November 06, 2018
News Conference News TCT 2018 Eluvia Gains FDA Approval Just Days After IMPERIAL Results Released Todd Neale September 24, 2018
News Conference News TCT 2018 IMPERIAL: Eluvia Tops Zilver PTX in Battle of DES in Femoropopliteal Disease Todd Neale September 22, 2018
News Conference News TCT 2018 TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More Shelley Wood September 17, 2018
News Conference News ESC 2018 BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for De Novo Small-Vessel Disease Todd Neale August 28, 2018
News Conference News EuroPCR 2018 DES Slightly Edge Out DCBs in Treatment of In-Stent Restenosis: Meta-analysis Caitlin E. Cox May 30, 2018